Iranian Journal of Public Health 2018. 47(2):209-218.

Effects of First Diagnosed Diabetes Mellitus on Medical Visits and Medication Adherence in Korea
Hyeongsu KIM, Soon-Ae SHIN, Kunsei LEE, Jong-Heon PARK, Tae Hwa HAN, Minsu PARK, Eunyoung SHIN, Hyoseon JEONG, Jung-Hyun LEE, Hyemi AHN, Vitna KIM



Background: The National Health Insurance Service (NHIS) conducted a screening test to detect chronic diseases such as hypertension and diabetes in Korea. This study evaluated the effects of health screening for DM on pharmacological treatment.

Methods: The data from qualification and the General Health Screening in 2012, the insurance claims of medical institutions from Jan 2009 to Dec 2014, and the diabetic case management program extracted from the NHIS administrative system were used. Total 16068 subjects were included. Visiting rate to medical institution, medication possession ratio and the rate of medication adherence of study subjects were used as the indices.

Results: The visiting rates to medical institutions were 39.7%. The percentage who received a prescription for a diabetes mellitus medication from a doctor was 80.9%, the medication possession ratio was 70.8%, and the rate of medication adherence was 57.8%.

Conclusion: The visiting rate, medication possession ratio and rate of medication adherence for DM medication were not high. In order to increase the visiting rate, medication possession ratio and rate of medication adherence, NHIS should support environment in which medical institutions and DM patients can do the role of each part.



Diabetes mellitus, Health screening, Medical visit, Medication possession ratio, Appropriate medical adherence

Full Text:



American Diabetes Association, National Heart, Lung and Blood Institute et al (1999). Diabetes mellitus: a major risk fac-tor for cardiovascular disease. Circulation, 100: 1132–1133.

Korean Centers for Disease Control and Prevention (2014). Korea Health Statistics 2013: Korea National Health and Nutrition Examination Survey (KNHANES VI-1).

Statistics Korea (2014). 2013 Annual report on the causes of death statics. Seoul.

National Health Insurance Service, Health Insurance Review and Assessment Ser-vice (2013). 2012 National Health Insurance Statistical Yearbook. Sekwang Design Press. Seoul.

Ministry of Health and Welfare (2011). The National Health Plan 2020: The third national health promotion (2011 ~2020). Seoul.

National Health Insurance Service (2013). 2012 National Health Screening Statistical Yearbook. Sekwang Design Press. Seoul.

Jeong HJ, Kwon HY, Han JT et al (2008). Cost-Effectiveness Analysis of Type 2 DM Screening Program of National Health Insurance Corporation. Korean J Health Econ Policy, 14: 29-50.

Kim JS (2010). The cost-benefit analysis of Type 2 DM Screening Program of Na-tional Health Insurance Corporation. IT-BI Review, 16(2): 37-55.

Korean Centers for Disease Control and Prevention (2013). Cost-effectiveness analysis of mass screening for type 2 diabetes mellitus. Seoul.

National Evidence-based Healthcare Col-laborating Agency (2011). Study on evaluat-ing quality outcome of the national health screening program and developing strategies for future im-provement. Seoul.

Yeo JY, Jeong HS (2012). Determinants of health screening and its effects on health behaviors. Korean J Health Policy Administra-tion, 22(1); 49-64.

National Evidence-based Healthcare Col-laborating Agency (2013). The mortality rate and medical cost by the national health examina-tion analysis. Seoul.

Lee H, Cho J, Shin DW et al (2015). Associ-ation of cardiovascular health screening with mortality, clinical outcomes, and health care cost: a nationwide cohort study. Prev Med, 70: 19-25.

National Health Insurance Service (2011). The effect of National Health Examination Pro-gram on the early diagnosis of disease, medical utilization and health outcome. Seoul.

Karve S, Cleves MA, Helm M et al (2008). An empirical basis for standardizing ad-herence measures derived from adminis-trative claims data among diabetic pa-tients. Med Care, 46: 1125-1133.

Cramer JA (2004). A systematic review of adherence with medications for diabetes. Diabetes Care, 27:1218-1224.

Brown MT, Bussell JK (2011). Medication adherence: WHO cares? Mayo Clin Proc, 86: 304-314.

Clifford S, Perez-Nieves M, Skalicky AM et al (2014). A systematic literature review of methodologies used to assess medication adherence in patients with diabetes. Curr Med Res Opin, 30: 1071-1085.

Hong JS, Kang HC (2014). Relationship be-tween continuity of ambulatory care and medication adherence in adult patients with type 2 diabetes in Korea: a longitu-dinal analysis. Med Care, 52: 446-453.

An J, Nichol MB (2013). Multiple medica-tion adherence and its effect on clinical outcomes among patients with comorbid type 2 diabetes and hypertension. Med Care, 51: 879-887.

O'Shea MP, Teeling M, Bennett K (2013). An observational study examining the ef-fect of comorbidity on the rates of per-sistence and adherence to newly initiated oral anti-hyperglycaemic agents. Pharmaco-epidemiol Drug Saf, 22: 1336-1344.

Hsu C, Lemon JM, Wong ES et al (2014). Factors affecting medication adherence: patient perspectives from five veterans’ affairs facilities. BMC Health Serv Res, 14: 533.

Richards LC, Royalty J, Howe et al (2010). Timeliness of breast cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detec-tion Program, 1996-2005. Am J Public Health, 100: 1769-1776.

Benard VB, Howe W, Royalty J et al (2012). Timeliness of cervical cancer diagnosis and initiation of treatment in the National Breast and Cervical Cancer Early Detec-tions Program. J Womens Health (Larchmt), 21: 776-782.

Miller JW, Hanson V, Johnson GD et al (2014). From cancer screening to treat-ment: service delivery and referral in the National Breast and Cervical Cancer Early Detection Program. Cancer, 120 (Suppl 16): 2549-56.

Lau DT, Nau DP (2004). Oral antihypergly-cemic medication nonadherence and sub-sequent hospitalization among individuals with type 2 diabetes. Diabetes Care, 2004, 27(9):2149-53.


  • There are currently no refbacks.

Creative Commons Attribution-NonCommercial 3.0

This work is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported License which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.